v3.24.1.1.u2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2024
Sep. 30, 2023
Current assets:    
Cash and cash equivalents $ 11,495 $ 26,211
Restricted cash 495 495
Accounts receivable, net of allowances for credit losses of $299 and $356, respectively 13,901 15,575
Contract assets 8,097 8,402
Inventory 32,124 28,905
Prepaid expenses 3,721 4,612
Other current assets 397 922
Assets held for sale 3,552 7,264
Total current assets 73,782 92,386
Property, plant, and equipment, net 13,717 15,517
Operating lease right-of-use assets 20,051 21,564
Other intangible assets, net 11,258 12,245
Other non-current assets 2,189 2,201
Total assets 120,997 143,913
Current liabilities:    
Accounts payable 8,591 9,683
Accrued expenses and other current liabilities 7,637 8,471
Contract liabilities 2,278 1,630
Financing payable 0 460
Loan payable - current 852 852
Operating lease liabilities - current 3,148 3,033
Liabilities held for sale 37 4,662
Total current liabilities 22,543 28,791
Line of credit 4,582 6,418
Loan payable - non-current 2,904 3,330
Operating lease liabilities - non-current 19,309 20,882
Asset retirement obligations 4,316 4,194
Other long-term liabilities 8 8
Total liabilities 53,662 63,623
Commitments and contingencies
Shareholders’ equity:    
Common stock, no par value, 100,000 shares authorized; 8,895 shares issued and 8,204 shares outstanding as of March 31, 2024; 8,401 shares issued and 7,711 shares outstanding as of September 30, 2023 826,338 825,119
Treasury stock at cost; 691 shares as of March 31, 2024 and September 30, 2023 (47,721) (47,721)
Accumulated other comprehensive income 350 350
Accumulated deficit (711,632) (697,458)
Total shareholders’ equity 67,335 80,290
Total liabilities and shareholders’ equity $ 120,997 $ 143,913

Source

10-Q PDF XBRL Zip